• The 1st International Saudi Society Of Endocrinology And Metabolism Conference

  • Endocrinology, Diabetes, and Metabolism

  • Leading professionals in their respective field of practices, qualifications, trainings and experiences

About the Conference


The 1st International Saudi Society of Endocrinology and Metabolism Conference is to be held in Riyadh on 20-22 November 2012. It is first of its kind to be organized by the Saudi Society of Endocrinology and Metabolism (SSEM) at international level. Invitations are being sent out to over forty (40) speakers both local & international, and about one thousand (1000) medical professional attendees from kingdom and the GCC region are expected to attend. Upon their respective attendance, the attendees shall be awarded with thirty (30) CME hours accredited by the Saudi Commission for Health Specialties (SCHS).

The program is implemented to cover all those subjects related to Endocrinology, Dibetes, and Metabolism for both adults and pediatrics such as disorders of pituitary, thyrioid, adrenals, etc., as well as diabetes diseases, and metabolic bone disorders.

The program is set up with the objectives as such to update the healthcare professionals on the major topics of Endocrinology and Diabetes, also to promote the communication and networking among the attendees and the instituitions at local, regional and international levels, as well as to offer recommendations in regard to the best clinical practice.

The formats of the conference shall be planery lectures, lectures, workshops, and meet the expert.

About the Society (Organizer)


The Saudi Society of Endocrinology and Metabolism (SSEM) is a scientific health society in the field of Endocrinology, Diabetes and Metabolism for both adults and pediatrics with its services covering all provinces over the Kingdom of Saudi Arabia.

It was established under the umbrella of the Saudi Council for Health Specialties (SCHS) on 29th August 2009 with a mission to provide educational and other professional services for health professionals, the public and authorities in relation to the aspects of its field.

SSEM Board of Directors

The SSEM management and operation are supervised by the board of directors which is composed of eleven (11) members elected by the general assembly of SSEM.

Conference Steering Committee


The management of SSEM has formed a conference steering committee consisting of eighteen (18) members, who themselves are professional endocrinologists and experts in their respective specialties. The committee is dedicated to oversee and steer the processes of organizing the conference in the manner in which it would be best delivered.

Dr. Atallah Al Ruhaily
President, Saudi Society of Endocrinology and Metabolism (SSEM)
Chairman, SSEM Board of Directors
Chairman, Conference Steering Committee

Dr. Saleh Al Jaser
Vice President, Saudi Society of Endocrinology and Metabolism (SSEM)
Deputy Chairman, SSEM Board of Directors
Deputy Chairman, Conference Steering Committee
Head of Scientific Committee: Diabetes Mellitus

Dr. Essa Al Dhafiri
Treasurer, Saudi Society of Endocrinology and Metabolism (SSEM)
Treasurer, SSEM Board of Directors
Treasurer, Conference Steering Committee

Dr. Murad Murad
Member, SSEM Board of Directors
Deputy Head of Finance Committee

Dr. Hussein Raef
Member, SSEM Board of Directors
Head of Scientific Committee: Adult Endocrinology

Dr. Sohail Inaam
Deputy Head of Scientific Committee: Adult Endocrinology

Dr. Angham Al Mutair
Head of Scientific Committee: Pediatric Endocrinology

Dr. Afaf Alsagheir
Deputy Head of Scientific Committee: Pediatric Endocrinology

Dr. Abdul Raoof Al Mahfouz
Deputy Head of Scientific Committee: Diabetes Mellitus

Dr. Bassam Bin-Abbas
Member, SSEM Board of Directors
Head of Media Committee

Dr. Anwar Al Jammah
Deputy Head of Media Committee

Dr. Naji Al Johani
Member, SSEM Board of Directors
Head of Admin Committee

Dr. Mohammad Al Harbi
Member of Admin Committee

Dr. Ali Al Zahrani
Member, SSEM Board of Directors
Member, Conference Steering Committee

Dr. Aishah Ekhzaimy
Member, SSEM Board of Directors
Member, Conference Steering Committee

Dr. Eman Al Fadhli
Member, SSEM Board of Directors
Member, Conference Steering Committee

Dr. Salwa Al Aidarous
Member, SSEM Board of Directors
Member, Conference Steering Committee

Dr. Abdul Aziz Al Twaim
Member, Conference Steering Committee

Scientific Program


The program is implemented to cover all those subjects related to Endocrinology, Diabetes Mellitus, and Metabolism for both adults and pediatrics including but not limited to disorders of pituitary, gonads, thyroid, parathyroid, adrenals, as well as diabetes diseases and metabolic bone disorders.

To download a copy of the scientific program, please Click Here



From around the globe, we have selected a large number of distinguished speakers among the experts in their respective field of practice. To view more details about the speakers and their profiles, please click here.

Speakers (Flash Album)



Click here to Register Online

Registration desk contact:

Email: conference@endocrine.org.sa
Tel.: +966 1 4690 158
Fax: +966 1 4690 806


Registration Fee

SAR 200: Early Bird, before 15 Oct 2012
SAR 300: Pre-Registration, On/After 15 Oct 2012
SAR 400: Registration Onsite, On/After 20 Nov 2012

To register, please follow the three steps as per below:

Step 1: Register with either of the options

Option 1: Register Online

To register online visit http://events.endocrine.org.sa/registration.aspx

Option 2: Application Form

You may also fill out /complete the registration form (click here) and send us either by email(conference@endocrine.org.sa) or fax.

Step 2: To confirm your participation, please deposit your payment with either of the options

Option 1: Bank Wire

Recipient (English)

Saudi Society of Endocrinology and Metabolism

Recipient (Arabic)

الجمعية السعودية للغدد الصم والاستقلاب

Account number





National Commercial Bank (NCB) البنك الأهلي التجاري

Option 2: Cash Onsite

SSEM Head Office,
Office No. 242, 2nd Floor, In the Al Kheraiji Bookstore Building,
Near Sahel Petrol / Gas Station, Close to King Fahad Medical City, Riyadh

Office Hours: Sat. to Wed. 8-4, Thu. 8-12

Office to Receive Payments : 01 4611 373
Conference Organizer’s Office : 01 4690 158
Conference Organizer’s Fax : 01 4690 806

Step 3: After payment, send a copy of receipt by email or fax with the name of the applicant

Conference Organizer’s Office : conference@endocrine.org.sa

Conference Organizer’s Fax : 01 4690 806

PS: If a VISA is required for those who are intending to attend the conference from abroad, we do not have the authority to issue visa for you to enter KSA for your attendance, neither can we assist in this regard. Please check with The Royal Embassy of Saudi Arabia in your country.



Al Faisaliah Hotel, Riyadh



  • Platinum Sponsor
  • Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.

    With headquarters in Denmark, Novo Nordisk employs approximately 30,000 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange.

  • Gold Sponsor
  • MSD, also known as Merck in North America, is the second-largest healthcare company in the world and a global leader in consumer products and animal care. For more than 30 years, MSD Saudi Arabia has been preserving and improving human life by promoting access to medicines and vaccines and making these products available to all who need them. Through its local distributors, MSD Saudi Arabia provides innovative products based on the highest level of scientific excellence including products for cardiovascular issues, asthma, pain and inflammation, osteoporosis, neurological issues, and ophthalmic pathological disorders, in addition to several specialized hospital products and vaccines. MSD Saudi Arabia works closely with health providers in the Kingdom to facilitate and update their scientific and medical knowledge to better serve their patients.

  • Gold Sponsor
  • When science and passion connect, innovation happens.

    Novartis want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. Novartis oncology community shares a common mission to transform the way patients live with cancer and related diseases. At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. We seek to provide a broad range of new therapies as well as practical solutions to advance the care of patients. Connecting within the oncology community. Turning scientific possibility into clinical reality. With more than 120 000 associates in 140 countries worldwide, Novartis associates share a vision of a better today and tomorrow for patients – a vision that drives our growth and success. The greatest job satisfaction for our associates is the knowledge that they improve the quality of life for patients with increasing precision and efficiency through breakthrough science and innovation

    Novartis Consulting AG -Address: P.O. Box 16032 Riyadh 11464, SAUDI ARABIA. Phone: +966 1 4658882

  • Silver Sponsor
  • Pfizer Inc. - “Working Together for a Healthier World”

    Pfizer has been operating in Saudi Arabia since early 60’s and has greatly contributed to the development of healthcare industry in the country in many different ways including but not limited to developing and providing quality medicines, promoting health, raising awareness of various disease and therapeutic areas and prevention solution and partnership with the local government and private healthcare institutions.

    In October 2011, Pfizer Saudi Arabia inked a momentous agreement with the Saudi Arabian General Investment Authority (SAGIA) to set up its first ever manufacturing plant throughout the GCC at King Abdullah Economic City, Saudi Arabia.

  • Silver Sponsor
  • “Lilly Diabetes..Personal solutions for everyday life”

    Lilly has been a global leader in diabetes care since 1923, when it introduced the world’s first commercial insulin. Today Lilly Diabetes works to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio, and a continued commitment to providing real solutions—from medicines to support programs and more—to make people with Diabetes lives better

  • Silver Sponsor

    Boehringer Ingelheim & Eli Lilly have announced Diabetes Alliance in January 2011. This alliance will leverage the collective scientific expertise & business capabilities of two leading research-driven pharmaceutical companies to address patients’ needs arising from the growing global diabetes epidemic.

    This alliance is one of the largest ever in a single therapeutic area among two pharmaceutical companies and aims to provide a portfolio of treatments for patients with diabetes and their healthcare professionals. The alliance has one of the most robust combined late-stage development pipelines in diabetes and it has enabled the two companies to double their strength to better help patients and health care providers manage diabetes across the different stages of the condition.

  • Bronze Sponsor
  • BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide

    BD Worldwide Segments: BD Diabetes Care, BD Medical, BD Diagnostics, BD Bioscience, BD Pre Analytical Systems

  • Bronze Sponsor


  • Bronze Sponsor
  • "Every year, more than seven million patients benefit from our products and therapies."
    At Medtronic, we're committed to Innovating for life by pushing the boundaries of medical technology and changing the way the world treats chronic disease. Driven by our deep understanding of the human body and our collaboration with physicians, we're transforming technology to treat patients across the entire care continuum. Our innovations help physicians diagnose diseases earlier, treat patients with the least amount of disruption possible, and help alleviate symptoms throughout the patient's life. Today, we're improving the lives of millions of people worldwide each year across numerous conditions - including heart disease, diabetes, neurological disorders, spinal conditions, and vascular diseases. But it isn't enough. So we're innovating beyond products. We're breaking down barriers, challenging assumptions, and looking beyond the status quo - to continually find more ways to help people live better, longer.
    Medtronic was founded in 1949 as a medical equipment repair company by Earl Bakken and his brother-in-law, Palmer Hermundslie. Today, we're the world's largest independent medical technology company. We employ 45,000 people worldwide - serving physicians, clinicians, and patients in more than 120 countries.





Photo Gallery:

"New contents will be displayed soon"


Video Gallery:

"New contents will be displayed soon"


Audio Gallery:

"New contents will be displayed soon"